TSUTOMU HIROSHIGE,CHIKASHI OGURA AND SHINJI ITOH Department of Physiology, Hokkaido University School of Medicine, Sapporo SYNOPSIS ACTH-releasing potency of a purified hypothalamic CRF of pig origin was examined by use of the intrapituitary microinjection method. A good log doseresponse relationship was obtained in the dosage range from 12.5 to 50 ng injected per one anterior pituitary lobe. Two dose factorial analysis showed that the difference in response between purified CRF and median eminence extract of the rat at corresponding dosage levels was not significant and that parallelism was well maintained with a highly significant combined slope. Relative potency of the median eminence extract was calculated to be 102%. From these findings it was estimated that the median eminence of the rat would contain the CRF of the order of 600 ng.
The modern concept on hypothalamic neurohumoral integration of adenohypophysial functions postulates the existence in the hypothalamus of several specific substances related to the secretion of corresponding pituitary tropic hormones. Among these postulated substances, corticotropin-releasing factor (CRF) was claimed for the first time by Saffran et al. (1955) and independently by Guillemin and Rosenberg (1955) to exist, as distinct from neurohypophysial hormones, in the posterior pituitary lobe. Although CRF in the neurohypophysis was proposed to be a peptide (Schally et al., 1960 (Schally et al., , 1962 Schally and Guillemin, 1963) , the chemical nature of the hypothalamic CRF has not been clear yet (Guillemin, 1967) , and therefore determination of dynamics of CRF activity in the hypothalamic tissue under varying conditions may chiefly depend upon the adequacy of an assay system employed for detecting this elusive activity. Several criteria necessary for the determination of CRF activity have been extensively discussed (Leeman et al., 1962 : Guillemin, 1964 ) and Guillemin recommended strongly an adoption of an in vitro system along with an in vivo method for the validation of CRF, because it is well known that many non-specific stimuli may affect the intrinsic CRF activity of the assay animal.
In a previous paper (Hiroshige et al., 1968a) , we offered a new assay method for CRF activity, i.e. intrapituitary microinjection of test materials into the adenohypophysis, exposed parapharyngeally, of dexamethasoneNembutal blocked rats. This method is a modification of the original method of Hedge et al. (1966) , to observe the direct effect of releasing substances on the anterior pituitary tissue as in the case of in vitro methods, yet to enable the gland respond in situ to test materials, thus avoiding artifacts due to the incubation in artificial media. With this assay method, we have tested in the present experiment ACTH-releasing potency of a puri- (Hiroshige et al., 1968a) , the activity was then compared with that of the purified hypothalamic CRF at two dose levels as shown in Figure  2 . Two dose factorial analysis showed that the difference in response between the purified CRF and median eminence extract at corresponding dosage levels was not significant and that parallelism was well maintained with a highly significant combined slope (P<0.001). Relative potency of the extract was calculated to be 102%. From these results it was estimated that the median eminence of the rat would contain the CRF of the order of 600 ng, an amount several times larger than that of vasopressin present in the same tissue, as McCann and Haberland (1959) phasis should be laid on the specificity as well as sensitivity. Schally et al. (1965) Arimura et al. (1967) in chlorpromazine-morphine-Nembutal blocked rats. Consequently, main problem in in vivo systems for assaying CRF activity in crude extracts appears to lie in the difficulties in separating the potency of CRF from that of vasopressin. Since we have already shown (Hiroshige et al., 1968b ) that either of the posterior pituitary hormones, when placed directly into the adenohypophysis, is virtually devoid of CRF activity, an advantage of the direct microinjection method is apparent. As to the sensitivity of this method, comparison Endocrinol. Japon. Sept. 1968 of the minimum effective doses is relevant. Earlier, Guillemin et al. (1959) physis elicited a significant ACTH release are therefore taken as evidence for much higher sensitivity of our intrapituitary microinjection method for assessing CRF activity.
